Injectable Steroids

Tren A 100 mg Selliza Pharma

Selliza Pharma

55,00

In Stock (100 available)

Tren A 100 mg Selliza Pharma (100 mg) — Backed by Selliza Pharma’s commitment to quality, widely regarded as the most powerful anabolic steroid available — rated at 500…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Trenbolone Acetate, Selliza Pharma, 100 mg. Short-ester tren for users who want dose-control. Cycle length 6–10 weeks; start at 200 mg/week to assess tolerance before increasing. Cabergoline on hand for prolactin management.

Key Benefits

  • Most potent AR agonist in common use — ~5× testosterone affinity
  • No aromatisation — zero oestrogen conversion, no water retention
  • Dramatic nutrient-partitioning — recomp on maintenance calories
  • Progestagenic — cabergoline for prolactin control
  • Short ester — fast onset, fast exit, EOD pinning minimum
  • Each unit dosed at 100 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 50–100 mg every other day (150–350 mg/week effective). First-time tren users start at 50 mg EOD for 2 weeks to gauge tolerance. Cycles 8–10 weeks — the compound does not reward longer runs.

How It Works

19-nor derivative with C9 and C11 double-bond additions conferring extreme androgen-receptor affinity. Does not aromatise. Moderately progestagenic — raises prolactin in some users. Potent nutrient-partitioning effect: simultaneous lean-mass accrual and fat loss at maintenance calories.

Pharmacokinetics

Plasma half-life approximately 1 day (acetate ester). EOD minimum pinning; daily smoother. Rapid onset within days, rapid clearance (2 weeks). Short cycle tail makes PCT timing straightforward: start 3 days post-last-pin.

Potential Side Effects

Signature side-effects: night sweats, insomnia, aggression, cardiovascular stress, “tren cough” at injection. Not hepatotoxic but raises creatinine. Cabergoline 0.25 mg 2×/week for prolactin. HDL crashes. Not for beginners or anyone cardiovascular-risk.

Cycle & Stacking Guide

Advanced cutting or recomp, 8–10 weeks. Standard stack: test 200–300 mg/week + tren ace 200–300 mg/week + masteron or winstrol. Not a first cycle. Monitor resting HR, BP, and sleep quality throughout.

Manufacturer Notes

Selliza Pharma focuses on injectable blends with standardised concentrations. Tamper-evident vial caps; batch-date coded labels.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Tren A 100 mg Selliza Pharma”

Your email address will not be published. Required fields are marked *

Trenbolone Acetate

Physical & Chemical Properties for Research Purposes
Chemical structure of Trenbolone Acetate (C20H24O3) for laboratory analysis
2D structural representation · PubChem CID 24822 ↗
Chemical Identity
# CAS Registry Number 10161-34-9
Σ IUPAC Name [(8S,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,14-hexahydro-1H-cyclopenta[a]phenanthrene-17-yl] acetate
F Molecular Formula C20H24O3
M Molecular Weight 312.41 g/mol
SMILES CC(=O)O[C@@H]1CC[C@@H]2C3=CC=C4CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C
InChIKey FNYKCQMZFXUVMA-LKBHZCJUSA-N
Melting Point 96-97 °C
Solubility Practically insoluble in water; soluble in oils and organic solvents
Biological Half-life 1 day (IM)
PubChem CID 24822 ↗
Pharmacological Profile
Anabolic Rating 500
Androgenic Rating 500
Aromatization None
Hepatotoxicity Low
Detection Time 5 months

Clinical Notes

19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.

Known trade names: Finajet, Finaplix, Trenbol

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.